John Libbey Eurotext




HIV - associated and non - HIV associated types of Kaposi’s sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence
European Journal of Dermatology. Volume 16, Number 6, 677-82, November-December 2006, Clinical report
Free Article
Author(s) : G Wamburu, EJ Masenga, EZ Moshi, P Schmid-Grendelmeier, W Kempf, CE Orfanos
Summary : In this study 77 patients with histologically confirmed Kaposi’s sarcoma (KS) were seen at the Regional Dermatology Training Centre (RDTC) in Moshi, Tanzania. Sixty six patients (85.7%) were HIV-seropositive KS-patients (40 males, 26 females\; male: female ratio 1.5:1), whereas another 11 (14.3%) KS-patients, all males, were found HIV-seronegative, thus corresponding to the endemic African KS-type. In both groups the CD 4 ⁺ cell counts were generally low, the CD8 ⁺ population increased and the CD4 ⁺/CD8 ⁺ ratio inverted. Immune suppression was, however, more prominent in the HIV-seropositive group.HHV-8 seroprevalence was high in patients with HIV-associated KS (94.6%), nevertheless, 3 (5.4%) patients in this group remained HHV-8 seronegative. All nine patients with the HIV-seronegative African type of KS were found positive for HHV-8. Of the entire group seen, males were more likely to be HHV-8 seropositive than females (OR \= 3.348 95% CI, 0.96-11.65\; p <\; 0.05). The relative risk to develop KS in individuals seropositive to both HIV and HHV-8 was high (OR \= 10.6, 95% CI\; 2.981-37.688\; p <\; 0.001).Overall, HIV-associated KS differed from the non-HIV-associated by its widespread clinical dissemination on the trunk, the frequent involvement of the oral mucosa and the craniofacial region, and its more rapidly progressive course. No histological differences between the two KS-groups were seen, although spindle cell infiltrates were more often found in the HIV-associated KS-group.
Keywords : Kaposi’s sarcoma, HIV, HHV-8, African endemic KS, epidemic KS

HIV - associated and non - HIV associated types of Kaposi’s sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence